[go: up one dir, main page]

DE69819643D1 - Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay - Google Patents

Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay

Info

Publication number
DE69819643D1
DE69819643D1 DE69819643T DE69819643T DE69819643D1 DE 69819643 D1 DE69819643 D1 DE 69819643D1 DE 69819643 T DE69819643 T DE 69819643T DE 69819643 T DE69819643 T DE 69819643T DE 69819643 D1 DE69819643 D1 DE 69819643D1
Authority
DE
Germany
Prior art keywords
immunoassay
incubation
immobilised
labeled antigen
labelled antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819643T
Other languages
English (en)
Other versions
DE69819643T2 (de
Inventor
Justin Mark Glover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Ltd
Original Assignee
Ortho Clinical Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Ltd filed Critical Ortho Clinical Diagnostics Ltd
Application granted granted Critical
Publication of DE69819643D1 publication Critical patent/DE69819643D1/de
Publication of DE69819643T2 publication Critical patent/DE69819643T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
DE69819643T 1997-09-11 1998-09-10 Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay Expired - Lifetime DE69819643T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9719357.7A GB9719357D0 (en) 1997-09-11 1997-09-11 Immunoassay Utilizing Two Incubations With Labelled Antigen
GB9719357 1997-09-11
US09/141,887 US6121006A (en) 1997-09-11 1998-08-28 Immunoassay utilizing two incubations with labeled antigen

Publications (2)

Publication Number Publication Date
DE69819643D1 true DE69819643D1 (de) 2003-12-18
DE69819643T2 DE69819643T2 (de) 2004-12-02

Family

ID=26312227

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819643T Expired - Lifetime DE69819643T2 (de) 1997-09-11 1998-09-10 Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay

Country Status (10)

Country Link
US (1) US6121006A (de)
EP (1) EP0902286B1 (de)
JP (1) JPH11148936A (de)
AT (1) ATE254286T1 (de)
CA (1) CA2246896C (de)
DE (1) DE69819643T2 (de)
DK (1) DK0902286T3 (de)
ES (1) ES2210678T3 (de)
GB (1) GB9719357D0 (de)
PT (1) PT902286E (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
CA2446246A1 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
GB0128583D0 (en) 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US7514191B2 (en) * 2006-04-26 2009-04-07 Xerox Corporation Imaging member
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
KR101990958B1 (ko) * 2016-08-31 2019-06-21 휴마시스 주식회사 면역학적 측정을 이용한 hiv 1형, 2형 및 o형 동시 진단용 키트 및 이를 이용한 동시 진단방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789628A (en) * 1986-06-16 1988-12-06 Vxr, Inc. Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices
WO1988009933A1 (en) * 1987-06-09 1988-12-15 Walker Laboratories Ltd. Immunoassay method
ATE132267T1 (de) * 1987-10-30 1996-01-15 Abbott Lab Immuntest unter verwendung von antigenen, produziert in heterologen organismen
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DE4120412C1 (de) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De

Also Published As

Publication number Publication date
JPH11148936A (ja) 1999-06-02
EP0902286A3 (de) 2000-02-23
CA2246896A1 (en) 1999-03-11
ES2210678T3 (es) 2004-07-01
DK0902286T3 (da) 2004-02-02
PT902286E (pt) 2004-03-31
EP0902286B1 (de) 2003-11-12
DE69819643T2 (de) 2004-12-02
EP0902286A2 (de) 1999-03-17
US6121006A (en) 2000-09-19
CA2246896C (en) 2006-04-04
ATE254286T1 (de) 2003-11-15
GB9719357D0 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
NO20001273L (no) Immunanalyse for BNP
AR006016A1 (es) Metodo para determinar h.pylori en muestras fecales y un equipo (kit) para realizar dicho metodo
NO970292L (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
KR960018584A (ko) 특이성 결합검정용 시약
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
ES2080099T3 (es) Ensayo para la hepatitis c.
NZ330475A (en) Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation
ATE235684T1 (de) Sensitivitätssteigerung bei der immunchemischen bestimmung eines analyten
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
FI874280A0 (fi) Immunometriskt bestaemningsfoerfarande.
GB2008247A (en) Detecting or quantifying substances using labelling techniques
DE3874741D1 (de) Immunassay-verfahren.
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
ATE323286T1 (de) Verfahren zum bestimmen von autoantikörpern
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
DE69917378D1 (de) Methylorange verwendende spezifische bindungsassays
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
ES2029890T3 (es) Inmunoensayo.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente
DK0565903T3 (da) Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN